Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2006 Jan 7;12(1):82-8.
doi: 10.3748/wjg.v12.i1.82.

Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole

Fabio Baldi  1 , Roberta Cappiello, Carlotta Cavoli, Stefania Ghersi, Francesco Torresan, Enrico Roda
Affiliations
Randomized Controlled Trial

Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole

Fabio Baldi et al. World J Gastroenterol. .

Abstract

Aim: To compare two different daily doses of lansoprazole given for 12 weeks and to assess the role of gastrointestinal (GI) investigations as criteria for selecting patients.

Methods: Out of 45 patients referred for unexplained chronic persistent cough, 36 had at least one of the GI investigations (endoscopy, 24-h esophageal pH-metry and a 4-week trial of proton pump inhibitor (PPI) therapy) positive and were randomly assigned to receive either 30 mg lansoprazole o.d. or 30 mg lansoprazole b.i.d. for 12 weeks. Symptoms were evaluated at baseline (visit 1) after the PPI test (visit 2) and after the 12-week lansoprazole treatment period (visit 3).

Results: Thirty-five patients completed the study protocol. Twenty-one patients (60.0%) reported complete relief from their cough with no difference between the two treatment groups (58.8% and 61.1% had no cough in 30 mg lansoprazole and 60 mg lansoprazole groups, respectively). More than 80% of the patients who had complete relief from their cough at the end of the treatment showed a positive response to the PPI test.

Conclusion: Twelve weeks of lansoprazole treatment even at a standard daily dose, is effective in patients with chronic persistent cough. A positive response to an initial PPI test seems to be the best criterion for selecting patients who respond to therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Percentage of patients showing symptomatic response at the end of 12-wk treatment with 30 mg/d (n = 17) or 60 mg/d (n = 18) lansoprazole.
Figure 2
Figure 2
Percentage of patients showing symptomatic response at the end of 12-wk treatment with 30 or 60 mg/d lansoprazole (n = 35), subdivided according to the outcome of PPI test. P<0.05 vs negative PPI test.
See this image and copyright information in PMC

References

    1. Richter JE. Extraesophageal presentations manifestations of gastroesophageal reflux disease. Semin Gastrointest Gastroenterol Dis. 1997;8:75–89. - PubMed
    1. Irwin RS, Richter JE. Gastroesophageal reflux and chronic cough. Am J Gastroenterol. 2000;95:S9–14. - PubMed
    1. Irwin RS, Curley FJ, French CL. Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am Rev Respir Dis. 1990;141:640–647. - PubMed
    1. Ours TM, Kavuru MS, Schilz RJ, Richter JE. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol. 1999;94:3131–3138. - PubMed
    1. Kiljander TO, Salomaa ER, Hietanen EK, Terho EO. Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole. Eur Respir J. 2000;16:633–638. - PubMed

Publication types